Related Experiment Video
Updated: Aug 6, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Platelet Function Disorders: Glanzmann Thrombasthenia and Type 2 Von Willebrand Disease
Navin Raj Ramamurthy1, Shashank M1, Sugil E2
1Institute of Internal Medicine, Madras Medical College, Chennai, IND.
None:
Bleeding disorders represent a broad spectrum of conditions that disrupt normal clot formation through abnormalities in platelet function or the coagulation cascade. Disorders affecting primary hemostasis typically manifest as mucosal bleeding, whereas abnormalities in secondary hemostasis more often lead to deep tissue hemorrhage. However, certain conditions, such as von Willebrand disease, may involve features of both pathways, complicating clinical evaluation. This report describes two adolescent patients who presented with mucocutaneous bleeding but were ultimately diagnosed with different underlying conditions: Glanzmann thrombasthenia and type 2 von Willebrand disease. The first patient exhibited recurrent gingival bleeding with normal platelet counts and near-normal coagulation studies. Further evaluation using platelet aggregation testing revealed impaired responses to multiple agonists, consistent with a defect in platelet aggregation. The second patient presented with gingival bleeding and severe menorrhagia and was initially treated as a case of hemophilia due to reduced factor VIII levels. Lack of therapeutic response prompted further testing, which demonstrated abnormal von Willebrand factor activity, confirming a qualitative defect. These cases highlight the importance of correlating clinical presentation with specialized laboratory investigations. Reliance on routine tests alone may lead to misdiagnosis, whereas a systematic diagnostic approach allows accurate identification and appropriate management of bleeding disorders.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

